Spontaneous Cholecysto- and Hepatolithiasis in Mdr2-/- Mice: A Model for Low Phospholipid-Associated Cholelithiasis

Hepatology

Volumn 39, Issue 1, 2004, Pages 117-128

  Lammert, Frank ^a,b   Wang, David Q H ^b   Hillebrandt, Sonja ^a   Geier, Andreas ^a   Fickert, Peter ^c   Trauner, Michael ^c   Matern, Siegfried ^a   Paigen, Beverly ^d   Carey, Martin C ^b  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF GRAZ   (Austria)

^d JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MULTIDRUG RESISTANCE PROTEIN 2; PHOSPHOLIPID; ABC TRANSPORTER; CHOLESTEROL; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT STONE; CHOLELITHIASIS; CONTROLLED STUDY; CRYSTALLIZATION; DISEASE MODEL; DISEASE PREDISPOSITION; FEMALE; GALLSTONE; INFRARED SPECTROSCOPY; KNOCKOUT MOUSE; MALE; MASS SPECTROMETRY; MICROSCOPY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RISK FACTOR; SUCROSE DENSITY GRADIENT CENTRIFUGATION; ANIMAL; BILE; BILE DUCT; CHEMISTRY; GALLBLADDER; GENETICS; LIVER; METABOLISM; MOUSE MUTANT; MOUSE STRAIN; PATHOLOGY; PATHOPHYSIOLOGY; SEX DIFFERENCE;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BILE; BILE DUCTS; CHOLELITHIASIS; CHOLESTEROL; CRYSTALLIZATION; DISEASE MODELS, ANIMAL; FEMALE; GALLBLADDER; LIVER; MALE; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; P-GLYCOPROTEINS; PHENOTYPE; PHOSPHOLIPIDS; SEX FACTORS;

EID: 1442355466     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20022     Document Type: Article

References (55)

1. Smit JJM, Schinkel AH, Oude Elferink RPJ, Groen AK, Wagenaar E, van Deemtet L, Mol CAA, et al. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 1993;75:451-462.
2. Mauad TH, van Nieuwkerk CMJ, Dingemans KP, Smit JJM, Schinkel AH, Notenboom RGE, van den Bergh Weerman MA, et al. Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis. Am J Pathol 1994;145:1237-1245.
3. Oude Elferink RPJ, Ottenhoff R, van Wijland M, Smit JJM, Schinkel AH, Groen AK. Regulation of biliary lipid secretion by mdr2 P-glycoprotein in the mouse. J Clin Invest 1995;95:31-38.
4. Jacquemin E, de Vrec JM, Cresteil D, Sokal EM, Sturm E, Dumont M, Scheffer GL, et al. The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. Gastroenterology 2001;120:1448-1458.
5. Puglielli L, Amigo L, Arrese M, Nunez L, Rigotti A, Garrido J, Gonzalez S, et al. Protective role of biliary cholesterol and phospholipid lamellae against bile acid-induced cell damage. Gastroenterology 1994;107:244-254.
6. Fickert P, Zollner G, Fuchsbichler A, Stumptner C, Weiglein AH, Lammert F, Marschall HU, et al. Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles. Gastroenterology 2002;123:1238-1251.
7. Rosmorduc O, Hermelin B, Poupon R. MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis. Gastroenterology 2001;120:1459-1467.
8. Rosmorduc O, Hermelin B, Boelle PY, Parc R, Taboury J, Poupon R. ABCB4 gene mutation-associated cholelithiasis in adults. Gastroenterology 2003;125:452-459.
9. Konikoff FM, Chung DS, Donovan JM, Small DM, Carey MC. Filamentous, helical, and tubular microstructures during cholesterol crystallization from bile. Evidence that cholesterol does not nucleate classic monohydrate plates. J Clin Invest 1992;90:1155-1160.
10. Wang DQ-H, Carey MC. Complete mapping of crystallization pathways during cholesterol precipitation from model bile: influence of physical-chemical variables of pathophysiological relevance and identification of a stable liquid crystalline state in cold, dilute and hydrophilic bile salt-containing systems. J Lipid Res 1996;37:606-630.
11. Wang DQ-H, Carey MC. Characterization of crystallization pathways during cholesterol precipitation from human gallbladder biles: identical pathways to corresponding model biles with three predominating sequences. J Lipid Res 1996;37:2539-2549.
12. Wang DQ-H, Paigen B, Carey MC. Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: physical-chemistry of gallbladder bile. J Lipid Res 1997;38:1395-1411.
13. Van Nieuwkerk CMJ, Oude Elferink RPJ, Groen AK, Ottenhoff R, Tytgat GNJ, Dingemans KP, van den Bergh Weerman MA, et al. Effects of ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene. Gastroenterology 1996;111:65-171.
14. Van Nieuwkerk CMJ, Groen AK, Ottenhoff R, van Wijland M, van den Bergh Weerman MA, Tytgat GNJ, Offerhaus JJA, Oude Elferink RPJ. The role of bile salt composition in liver pathology of mdr2 (-/-) mice: differences between males and females. J Hepatol 1997;26:138-145.
15. Crawford AR, Smith AJ, Hatch VC, Oude Elferink RPJ, Borst P, Crawford JM. Hepatic secretion of phospholipid vesicles in the mouse critically depends on mdr2 or MDR3 P-glycoprotein expression. J Clin Invest 1997;100:2562-2567.
16. Oude Elferink RPJ, Ottenhoff R, van Wijland M, Frijters CMG, van Nieuwkerk C, Groen AK. Uncoupling of biliary phospholipid and cholesterol secretion in mice with reduced expression of mdr2 P-glycoprotein. J Lipid Res 1996;37:1065-1075.
17. Lammert F, Wang DQ-H, Paigen B, Carey MC. Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: integrated activities of hepatic lipid regulatory enzymes. J Lipid Res 1999;40:2080-2090.
18. Wang DQ-H, Lammert F, Paigen B, Carey MC. Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: pathophysiology of biliary lipid secretion. J Lipid Res 1999;40:2066-2079.
19. Hillebrandt S, Goos C, Matern S, Lammert F. Genome-wide analysis of hepatic fibrosis in inbred mice identifies the susceptibility locus Hfib1 on chromosome 15. Gastroenterology 2002;123:2041-2051.
20. Hesse A, Molt K. Technik der infrarotspektroskopischen Harnsteinanalyse. J Clin Chem Clin Biochem 1982;20:861-873.
21. Trotman BW, Morris TA, Sanchez HM, Soloway RD, Ostrow JD. Pigment versus cholesterol cholelithiasis: identification and quantification by infrared spectroscopy. Gastroenterology 1977;72:495-498.
22. Edwards JD, Adams WD, Halpert B. Infrared spectrums of human gallstones. Am J Clin Path 1958:236-238.
23. Konikoff FM, Carey MC. Cholesterol crystallization from a dilute bile salt-rich model bile. J Crystal Growth 1994;144:79-86.
24. Konikoff FM, Laufer H, Messer G, Gilat T. Monitoring cholesterol crystallization from lithogenic model bile by time-lapse density gradient ultracentrifugation. J Hepatol 1997;26:703-710.
25. Loomis CR, Shipley GG, Small DM. The phase behaviour of hydrated cholesterol. J Lipid Res 1979;20:525-535.
26. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37:911-917.
27. Bartlett GR. Phosphorus assay in column chromatography. J Biol Chem 1959;234:466-468.
28. Gurantz D, Laker MF, Hofmann AF. Enzymatic measurement of choline-containing phospholipids in bile. J Lipid Res 1981;22:373-376.
29. Carey MC. Critical tables for calculating the cholesterol saturation of native bile. J Lipid Res 1978;19:945-955.
30. Lehmann WD, Köster M, Erben G, Keppler D. Characterization and quantification of rat bile phosphatidylcholine by electrospray-tandem mass spectrometry. Anal Biochem 1997;246:102-110.
31. Brügger B, Erben G, Sandhoff R, Wieland FT, Lehmann WD. Quantitative analysis of biological membrane lipids at the low picomole level by nano-electrospray ionization tandem mass spectrometry. Proc Natl Acad Sci U S A 1997;94:2339-2344.
32. Konikoff FM, Cohen DE, Carey MC. Filamentous crystallization of cholesterol and its dependence on lecithin species in bile. Mol Cryst Liq Cryst 1994;248:291-296.
33. Rapaport H, Kuzmenko I, Lafont S, Kjaer K, Howes PB, Als-Nielsen J, Lahav M, et al. Cholesterol monohydrate nucleation in ultrathin films on water. Biophys J 2001;81:2729-2736.
34. Bonnett R, Davies JE, Hursthouse MB. Structure of bilirubin. Nature 1976;262:327-328.
35. Carey MC, Small DM. The characteristics of mixed micellar solutions with particular reference to bile. Am J Med 1970;49:590-608.
36. Carey MC, Montet JC, Phillips MC, Armstrong MA, Mazer NA. Thermodynamic and molecular basis for dissimilar cholesterol-solubilizing capacities by micellar solutions of bile salts: cases of sodium chenodeoxycholate and sodium ursodeoxycholate and their glycine and taurine conjugates. Biochemistry 1981;20:3637-3648.
37. Wang DQ-H, Tazuma S. Effect of β-muricholic acid on the prevention and dissolution of cholesterol gallstones in C57L/J mice. J Lipid Res 2002;43:1960-1968.
38. Heuman DM. Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions. J Lipid Res 1989;30:719-730.
39. Hay DW, Cahalane MJ, Timofeyeva N, Carey MC. Molecular species of lecithins in human gallbladder biles. J Lipid Res 1993;34:759-768.
40. Moschetta A, van Berge-Henegouwen GP, Porrincasa P, Palasciano G, van Erpecum KJ. Cholesterol crystallization in model biles: effects of bile salt and phospholipid species composition. J Lipid Res 2001;42:1273-1281.
41. Lammert F, Marschall HU, Glantz A, Matern S. Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management. J Hepatol 2000;33:1012-1021.
42. Shoda J, Oda K, Suzuki H, Sugiyama Y, Ito K, Cohen DE, Feng L, et al. Etiologic significance of defects in cholesterol, phospholipid, and bile acid metabolism in the liver of patients with intrahepatic calculi. HEPATOLOGY 2001;33:1194-1205.
43. Fracchia M, Pellegrino S, Secreto P, Gallo L, Masoero G, Pera A, Galatola G. Biliary lipid composition in cholesterol microlithiasis. Gut 2001;48:702-706.
44. Shaffer EA, Small DM. Biliary lipid secretion in cholesterol gallstone disease. The effect of cholecystectomy and obesity. J Clin Invest 1977;59:828-840.
45. Landi K, Sinard J, Crawford JM, Topazian M. Cholesterol crystal morphology in acalculous gallbladder disease. J Clin Gastroenterol 2003;36:364-366.
46. Carey MC, LaMont JT. Cholesterol gallstone formation. 1. Physical-chemistry of bile and biliary lipid secretion. Prog Liver Dis 1992;10:139-163.
47. Small DM. Role of ABC transporters in secretion of cholesterol from liver into bile. Proc Natl Acad Sci U S A 2003;100:4-6.
48. Schwab RG, Theis JH. Annual cyclicity of gallstone prevalence in deer mice (Peromyscus maniculatus gambeli). J Wildlife Dis 1989;25:462-468.
49. Holzbach RT, Marsh M, Hallberg MC. The effect of pregnancy on lipid composition of guinea pig gallbladder bile. Gastroenterology 1971;60:288-293.
50. Jenkins SA. Biliary lipids, bile acids and gallstone formation in hypovitaminotic C guinea pigs. Br J Nutr 1978;40:317-322.
51. Snowball S, de Ranter C, Fevery J. Lincomycin treatment of guinea pigs causes formation of pigmented phosphate containing gallbladder sludge and stones. J Hepatol 1989;9:159-166.
52. Taylor DR, Crowther RS, Cozart JC, Sharrock P, Wu J, Soloway, RD. Calcium carbonate in cholesterol gallstones: polymorphism, distribution, and hypotheses about pathogenesis. HEPATOLOGY 1995;22:488-496.
53. Konikoff FM, Cohen DE, Carey MC. Phospholipid molecular species influence crystal habits and transition sequences of metastable intermediates during cholesterol crystallization from bile salt-rich model bile. J Lipid Res 1994;35:60-70.
54. Sakomoto M, Tazuma S, Chayama K. Less hydrophobic phosphatidylcholine species simplify biliary vesicle morphology, but induce bile metastability with a broad spectrum of crystal forms. Biochem J 2002;362:105-112.
55. Van Erpecum KJ, Portincasa P, Gadellaa M, van de Heijning BJM, Renooij W, van Berge-Henegouwen GP. Effects of bile salt hydrophobicity on nucleation behaviour of cholesterol crystals in model bile. Eur J Clin Invest 1996;26:602-608.